Docosahexaenoic Acid in Preventing Recurrence in Breast Cancer Survivors

Conditions:   Ductal Breast Carcinoma in Situ;   Lobular Breast Carcinoma in Situ;   Paget Disease of the Breast;   Stage IA Breast Cancer;   Stage IB Breast Cancer;   Stage II Breast Cancer;   Stage IIIA Breast Cancer;   Stage IIIB Breast Cancer;   Stage IIIC Breast CancerInterventions:   Drug: docosahexaenoic acid;   Other: placebo;   Other: laboratory biomarker analysisSponsor:   National Cancer Institute (NCI)Recruiting - verified August 2014
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials